Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 688621.SS Stock
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Price Chart
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 688621.SS Financial and Trading Overview
Contents
- Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Price Chart
- Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 688621.SS Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Beijing Sun-Novo Pharmaceutical Research Co., Ltd.
- Q&A For Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Stock
| Beijing Sun-Novo Pharmaceutical Research Co., Ltd. stock price | 57.29 CNY |
| Previous Close | 61.77 CNY |
| Open | 61.58 CNY |
| Bid | 61.7 CNY x N/A |
| Ask | 61.75 CNY x N/A |
| Day's Range | 59.53 - 62.49 CNY |
| 52 Week Range | 50.31 - 85.71 CNY |
| Volume | 863.32K CNY |
| Avg. Volume | 690.15K CNY |
| Market Cap | 6.91B CNY |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 40.592106 |
| EPS (TTM) | 1.77 CNY |
| Forward Dividend & Yield | 0.6 (0.99%) |
| Ex-Dividend Date | May 12, 2023 |
| 1y Target Est | 75.04 CNY |
688621.SS Valuation Measures
| Enterprise Value | 6.49B CNY |
| Trailing P/E | 40.592106 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 9.079719 |
| Price/Book (mrq) | 7.315627 |
| Enterprise Value/Revenue | 8.529 |
| Enterprise Value/EBITDA | 34.22 |
Trading Information
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -13.51% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 85.71 CNY |
| 52 Week Low | 50.31 CNY |
| 50-Day Moving Average | 65.39 CNY |
| 200-Day Moving Average | 70.44 CNY |
688621.SS Share Statistics
| Avg. Volume (3 month) | 690.15K CNY |
| Avg. Daily Volume (10-Days) | 492.97K CNY |
| Shares Outstanding | 112M |
| Float | 62.95M |
| Short Ratio | N/A |
| % Held by Insiders | 43.62% |
| % Held by Institutions | 19.65% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.429 |
| Trailing Annual Dividend Yield | 0.69% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.1244 |
| Last Split Factor | 1.4:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 22.40% |
| Operating Margin (ttm) | 22.50% |
| Gross Margin | 53.38% |
| EBITDA Margin | 24.92% |
Management Effectiveness
| Return on Assets (ttm) | 7.68% |
| Return on Equity (ttm) | 19.43% |
Income Statement
| Revenue (ttm) | 761.08M CNY |
| Revenue Per Share (ttm) | 6.79 CNY |
| Quarterly Revenue Growth (yoy) | 57.09% |
| Gross Profit (ttm) | 375.46M CNY |
| EBITDA | 189.69M CNY |
| Net Income Avi to Common (ttm) | 170.49M CNY |
| Diluted EPS (ttm) | 1.52 |
| Quarterly Earnings Growth (yoy) | 43.50% |
Balance Sheet
| Total Cash (mrq) | 532.12M CNY |
| Total Cash Per Share (mrq) | 4.75 CNY |
| Total Debt (mrq) | 291.78M CNY |
| Total Debt/Equity (mrq) | 30.52 CNY |
| Current Ratio (mrq) | 2.057 |
| Book Value Per Share (mrq) | 8.434 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 17.41M CNY |
| Levered Free Cash Flow (ttm) | -139359312 CNY |
Profile of Beijing Sun-Novo Pharmaceutical Research Co., Ltd.
| Country | China |
| State | N/A |
| City | Beijing |
| Address | Building 7 |
| ZIP | 102200 |
| Phone | 86 10 6074 8199 |
| Website | https://www.sun-novo.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 786 |
Beijing Sun-Novo Pharmaceutical Research Co., Ltd., a contract research company, engages in the research and development of chemical drugs and peptide drugs in China. The company offers small molecule chemical generic drugs; peptide products; and drugs for indications, such as impetigo, acne, renal anemia, chronic kidney disease dialysis patient hyper parathyroid hormone, analgesia, and other symptoms. It also provides packaging material compatibility test, impurity research, extract research, migration research, safety evaluation, and other research services; consistency evaluation services; clinical research services; registration consulting and agency services; and range of pharmacokinetics-pharmacodynamics and GLP bioanalysis services, including pharmacokinetic bioanalysis, immunogenic biology analysis, pharmacodynamics, and biomarker bioanalysis services. The company was founded in 2009 and is based in Beijing, China.
Q&A For Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Stock
What is a current 688621.SS stock price?
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 688621.SS stock price today per share is 57.29 CNY.
How to purchase Beijing Sun-Novo Pharmaceutical Research Co., Ltd. stock?
You can buy 688621.SS shares on the Shanghai exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Beijing Sun-Novo Pharmaceutical Research Co., Ltd.?
The stock symbol or ticker of Beijing Sun-Novo Pharmaceutical Research Co., Ltd. is 688621.SS.
Which industry does the Beijing Sun-Novo Pharmaceutical Research Co., Ltd. company belong to?
The Beijing Sun-Novo Pharmaceutical Research Co., Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Beijing Sun-Novo Pharmaceutical Research Co., Ltd. have in circulation?
The max supply of Beijing Sun-Novo Pharmaceutical Research Co., Ltd. shares is 120.02M.
What is Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. PE Ratio is 34.68361700 now.
What was Beijing Sun-Novo Pharmaceutical Research Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. EPS is 1.77 CNY over the trailing 12 months.
Which sector does the Beijing Sun-Novo Pharmaceutical Research Co., Ltd. company belong to?
The Beijing Sun-Novo Pharmaceutical Research Co., Ltd. sector is Healthcare.